Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity Gains on Diagnostics Strength, Faces China Headwinds
04:06pm, Monday, 06'th Apr 2026
RVTY gains from strong diagnostics and software growth, but China weakness, soft demand, and margin pressures temper its near-term outlook.
Allspring Global Investments Holdings LLC Raises Holdings in Revvity Inc. $RVTY
03:21am, Tuesday, 31'st Mar 2026
Allspring Global Investments Holdings LLC increased its position in Revvity Inc. (NYSE: RVTY) by 127.0% in the undefined quarter, according to the company in its most recent filing with the SEC. The f
Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
06:20pm, Tuesday, 10'th Mar 2026
Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?
12:31pm, Wednesday, 04'th Mar 2026
Revvity (RVTY) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
10:21am, Wednesday, 04'th Mar 2026
RVTY gains from strong diagnostics demand and fast-growing Signals software, but China policy pressure and weak research spending temper near-term growth.
Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
05:12pm, Tuesday, 03'rd Mar 2026
Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
09:57am, Monday, 02'nd Mar 2026
Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Revvity to Present at Upcoming Investor Conferences
08:00am, Tuesday, 17'th Feb 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: Raymond James 47th Annual Institutional Investors Conference Monday,
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
08:00am, Thursday, 05'th Feb 2026
WALTHAM, Mass.--(BUSINESS WIRE)-- #LifeSciences--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high
Revvity: Close To A Buy, Not Quite There
01:35pm, Tuesday, 03'rd Feb 2026
Diagnostics is driving Revvity, Inc. growth, especially outside China. Signals software a standout: high-teens growth, SaaS ARR +40%. China immunodiagnostics and NIH funding remain key drags.
Here's Why Revvity (RVTY) is a Strong Momentum Stock
10:50am, Tuesday, 03'rd Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
09:20am, Tuesday, 03'rd Feb 2026
Revvity Inc. (NYSE: RVTY) on Monday reported better-than-expected earnings for the fourth quarter.
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives
02:01pm, Monday, 02'nd Feb 2026
Adjusted EPS: $5.06 for the full year, surpassing initial guidance.Organic Growth: 3% for the year, within original guidance range.Diagnostic Segment Organic G
Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
12:30pm, Monday, 02'nd Feb 2026
Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
Revvity's Strong Performance Overshadowed by Market Uncertainty
11:14am, Monday, 02'nd Feb 2026
Revvity's (RVTY) stock is trading lower despite achieving its largest EPS upside in the past five quarters. The company reported a revenue growth of 5.9% year-o
